Hepatitis C virus antibodies and other markers of blood-transfusion- transmitted infection in multi-transfused Cuban patients

Journal of Clinical Virology

Volumn 34, Issue SUPPL. 2, 2005, Pages

  Ballester, José M ^a   Rivero, René A ^a   Villaescusa, Rinaldo ^a   Merlín, Julio C ^a   Arce, Ada A ^a   Castillo, Dunia ^a   Lam, Rosa M ^a   Ballester, Adalberto ^b   Almaguer, Miguel ^c   Melians, Silvia M ^d   Aparicio, José L ^e  

^a INSTITUTO DE HEMATOLOGÍA E INMUNOLOGÍA   (Cuba)

^b HOSPITAL CLINICOQUIRÚRGICO HERMANOS AMEIJEIRAS   (Cuba)

^c Dr Abelardo Buch López Institute of Nephrology   (Cuba)

^d Abel Santamaría University Clinical and Surgical Hospital   (Cuba)

^e Dr Serafín Ruíz de Zárate Higher Institute for Medical Sciences   (Cuba)

Author keywords

Antibody prevalence; Blood transfusion; HBV; HCV; HIV 1 2; Multi transfused patients

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY TITER; ARTICLE; BLOOD TRANSFUSION; CHILD; CONTROLLED STUDY; CUBA; DISEASE TRANSMISSION; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RATE; INFECTION RISK; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SEROLOGY; STATISTICAL ANALYSIS; TORQUE TENO VIRUS; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; CUBA; DISEASE TRANSMISSION, HORIZONTAL; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; INFANT; MALE; MIDDLE AGED; RENAL DIALYSIS; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES;

EID: 32044454048     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(05)80033-2     Document Type: Article

References (40)

1. Acosta-Rivero N., Alvarez-Obregon J.C., Musacchio A., Falcon V., Dueñas-Carrera S., and Marante J. In vitro self-assembled HCV core virus-like particles induce a strong antibody immune response in sheep Biochem Biophys Res Commun 290 1 2002 300 304
2. Alter M.J. Hepatitis C virus infection in the United States J Hepatol 31 Suppl 1 1999 88 91
3. Alter M.J., Hadler S.C., Judson F.N., Mares A., Alexander W.J., and Hu Y.P. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection JAMA 264 1990 2231 2235
4. Alter M.J., Kruszon-Moran D., Nainan O.V., McQuillan G.M., Gao F., and Moyer L.A. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 N Engl J Med 341 8 1999 556 562
5. Arús E., Infante M., Pérez M., and Winograd R. Fiebre de origen desconocido e infección crónica por et virus de la hepatitis C Rev Cub Med 34 3 1995 209 211
6. Arús E., Rivera L., Fernández A., Infante M., Jorge R., and Soto G. Tratamiento de la hepatitis C con interferón alfa 2b recombinante: ensayo clínico controlado aleatorizado Rev Cub Med 39 1 2000 12 20
7. Arús E., Rivera L., Infante M., Pérez M., Soto G., and Gra B. Tratamiento de la hepatitis viral aguda C con interferón alfa 2b recombinante: ensayo clínico Rev Cub Med 39 1 2000 21 29
8. Boyle B. Treatment of HCV infection in HI HCV Coinfected Patients Baker R. Critical Issues in the Treatment and Management of Chronic Hepatitis C 2005
9. Cendorogh Neto M., Mauzano S.I., Canziani M.E., Silva A.E., Cirenza L.F., and Sesso R. de C. Environmental transmission of hepatitis B and hepatitis C viruses within the hemodialysis unit Artif Organs 19 3 1995 251 255
10. Chaudhuri S., Das S., Chowdhury A., Santra A., Bhattacharya S.K., and Naik T.N. Molecular epidemiology of HCV infection among acute and chronic liver disease patients in Kolkata, India J Clin Virol 32 2005 38 46
11. Choo Q.L., Kuo G., Weiner A.J., Overby L.R., and Bradley D.W. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome Science 244 1989 359 362
12. Covas D.T., Boturao Neto E., and Zago M.A. The frequency of blood-born viral infections in a population of multitransfused Brazilian patients Rev Inst Med Trop Sao Paulo 35 3 1993 271 273
13. Cruz O., Pérez M.T., Izquierdo M., Lobaina L., Ruibal I., and Silva E. Evaluación de un sistema de Western blot (DAVIH-blot) para la confirmación de anticuerpos al VIH-1 Rev Cub Med Trop 49 1 1997 28 32
14. Delgado G. Situación de la hepatitis C en Cuba. Unidad de Análisis y Tendencias de Salud (UATS) Reporte Técnico de Vigilancia 4 1 1999 1
15. Falcón V., García C., de la Rosa M.C., Menéndez I., Seoane J., and Grillo J.M. Ultrastructural and immunocytochemical evidences of core-particle formation in the methylotrophic Pichia pastoris yeast when expressing HCVstructural proteins (core-E1) Tissue Cell 31 2 1999 117 125
16. Falcón V., Acosta-Rivero N., Chinea G., de la Rosa M.C., Menéndez I., and Dueñas-Carrera S. Nuclear localization of nucleocapsid-like particles and HCV core protein in hepatocytes of a chronically HCV infected patient Biochem Biophys Res Commun 310 1 2003 54 58
17. Falcón V., Acosta-Rivero N., Chinea G., Gavilondo J., de la Rosa M.C., and Menéndez I. Ultrastructural evidences of HCV infection in hepatocytes of chronically HCV-infected patients Biochem Biophys Res Commun 305 4 2003 1085 1090
18. Frank C., Mohamed M.K., Strickland G.T., Lavanchy D., Arthur R.R., and Magder L.S. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt Lancet 355 9207 2000 887
19. Galbán E., Padrón G., Arús E., González O., Rodríguez Z., and Mora S. Prevalencia del virus de la hepatitis C en donantes de sangre de Ciudad de la Habana Rev Cub Med Gen Integr 8 4 1992 324 329
20. Galbán E., Collado F., and Mora S. Seroprevalencia del virus de la hepatitis C en diferentes grupos de la población y factores de riesgo asociados Rev Cub Med Gen Integr 9 1 1993 52 62
21. González A., Machín S., Castañeda C., Svarch E., and Roque M.C. Estudio de las alteraciones hepáticas en un grupo de pacientes con leucemia aguda linfoblástica Rev Cubana Hematol Inmunol Hemoter 12 1 1997 12 21
22. Holland P.V. Post-transfusion hepatitis: current risks and causes Vox Sang 74 Supp1 2 1998 135 141
23. Hoomagie J.H. Posttransfusion hepatitis B Transfusion 30 1990 384 386
24. Illes M., Szontagh L., and Gal G. Hepatitis B virus markers and anti-HCV antibodies in hemodialysed patients Orv Hetil 133 Suppl 1 1992 27 30
25. Infante M., Arús E., Fernández A., and Gra B. Hallazgos clínicos, bioquímicos y morfológicos en 103 pacientes con anticuerpos contra et virus de la hepatitis C Rev Cub Med 37 2 1998 66 71
26. Jeffers L.J., Perez G.O., de Medina M.O., Ortiz-Iterian C.J., Schiff E.R., and Reddy K.R. Hepatitis C infection in two urban hemodialysis units Kidney Int 38 2 1990 320 322
27. Jilg W. Viral Hepatitis: A Clinical Guide 2001 Abbott Diagnostic Division Ginebra
28. Junco R. Infección por et virus de la hepatitis C en la población de Cienfuegos. Estudio clínico y epidemiológico Thesis Work to obtain the 1st. Specialist Degree in Internal Medicine 1994 "Dr. Gustavo Aldereguía Lima" University Clinical & Surgical Hospital Germany
29. Juneja M., Dubey A.P., Kumari S., Prakash C., and Mittal S.K. Hepatitis B and hepatitis C in multitransfused children Trop Gastroenterol 19 1 1998 34 36
30. Lauer G.M., and Walker B.D. Hepatitis C virus infection N Engl J Med 345 1 2001 41 52
31. Mukherjee S., and Dhawan V.K. George Y. Wu G.Y. Talavera F. Brann O.S. Mechaber A.J. Katz J. Hepatitis C 2004
32. Nomiyama K., Tsuji H., Keder K., Kawatoko T., Kashiwagi S., and Nakamura S. Prevalence of hepatitis C virus antibody in patients on chronic hemodialysis Fukuoka Igaku Zasshi 89 8 1998 232 237
33. Orton S.L., Stramer S.L., Dodd R.Y., and Alter M.J. Risk factors for HCV infection among blood donors confirmed to be positive for the presence of HCV RNA and not reactive for the presence ofanti-HCV Transfusion 44 2 2004 275 281
34. Padrón G., Aruz E., Roca J., Viña A., Lemus G., and Bacallao J. The Hepatitis C in Cuba: prevalence, antibody pattern, genotype and risk factor [Abstract] Hepatology 19 1994 1141
35. Rivero R.A., Hidalgo-Gato R., Martínez M., Hernández P., Ballester J.M., and Yamaguchi K. Antibodies to Hepatitis C Virus in Cuban Blood Donors Vox Sang 63 4 1992 285 286
36. Rivero R.A., Yamagushi K., Góngora M., Hidalgo-Gato R., Almagro D., and Hernández P. Prevalencia de anticuerpos contra et virus de la hepatitis C en pacientes cubanos con enfermedades hematológicas Rev Cubana Hematol Inmunol Hemoter 9 2 1993 127 130
37. Stramer S.L., Glynn S.A., Kleinman S.H., Strong D.M., Sally C., and Wright D.J. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing N Engl J Med 351 8 2004 760 768
38. (Suppl) Thorsteinsdóttir H., Saénz T.W., Quach U., Daar A.S., and Singer P.A. Cuba innovation through synergy Nature Biotechnology 22 2004 DC19 DC24
39. Weber B., Mühlbacher A., and Melchior W. Detection of an acute asymptomatic HBsAg negative hepatitis B virus infection in a blood donor by HBV DNA testing diagnostic J Clin Virol 32 2005 67 70
40. WHO/EMC/97.3 WHO Guidelines for the Safe Transport of Infectious Substances and Diagnostic Specimens 1997